Praxis Precision (PRAX) | Stock Overview & Key Data
Praxis Precision Performance Comparison
Stock Range
Today's Range
Low: $53.31
High: $55.86
on October 3, 2025
52 Week Range
Low: $26.70
High: $91.83
on April 9, 2025
on February 14, 2025
All-Time High: $914.27 on January 4, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.1B
EPS
-12.40
P/E Ratio (TTM)
-5.33
Forward P/E
-4.98
P/B Ratio
2.83
PEG Ratio
-0.06
Div. Yield
N/A
ROE
-60.98%
Beta
2.640
Debt to Equity
0.19
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-3,497.57%
Profit Margin
0.00%
Returns and Earnings
Return on Assets (TTM)
-37.98%
Return on Equity (TTM)
-60.98%
EBITDA
$-271.4M
Net Income (TTM)
$-251.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$0.40
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
-100.00%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Praxis Precision PRAX | 1.15B Small-cap | 3.70% | 16.82% | 15.07% | 63.30% | -31.61% | -16.26% | 64.79% | -86.96% |
| Vertex VRTX | 103.40B Large-cap | 4.55% | 1.68% | -12.25% | -16.68% | -0.61% | -11.42% | 36.61% | 49.40% |
| Regeneron REGN | 63.78B Large-cap | 6.40% | 6.42% | 9.62% | -1.74% | -16.11% | -40.76% | -16.94% | -0.34% |
| Vera Therapeutics VERA | 1.98B Small-cap | 6.88% | 31.27% | 25.58% | 32.54% | -28.58% | -26.20% | 51.00% | 162.09% |
| Dyne Therapeutics DYN | 1.95B Small-cap | -0.68% | -3.12% | 49.09% | 38.64% | -48.70% | -59.91% | 2.67% | -29.94% |
| Liquidia LQDA | 1.93B Small-cap | 2.89% | -23.24% | 84.00% | 58.74% | 85.37% | 101.17% | 312.32% | 316.91% |
Ownership & Short Interest
Insider Ownership
0.20%
Institutional Ownership
113.34%
Shares Short
2M
Short Ratio
5.79
Short % of Shares Outstanding
11.34%
Average 10-Day Volume
471K
Average 90-Day Volume
439K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PRAX's 52-week high and low?
- In the last 52 weeks, Praxis Precision reached a high of $91.83 (on February 14, 2025) and a low of $26.70 (on April 9, 2025).
- What is the market cap and P/E ratio for PRAX?
- Curious about Praxis Precision's size and valuation? Its market capitalization stands at 1.15B. When it comes to valuation, the P/E ratio (trailing twelve months) is -5.33, and the forward P/E (looking ahead) is -4.98.
- Does PRAX pay dividends? If so, what's the yield?
- As for dividends, Praxis Precision isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Praxis Precision's main competitors or similar companies to consider before investing?
When looking at Praxis Precision, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX103.40B Healthcare Biotechnology -11.42% 36.61% Regeneron
REGN63.78B Healthcare Biotechnology -40.76% -16.94% Vera Therapeutics
VERA1.98B Healthcare Biotechnology -26.20% 51.00% Dyne Therapeutics
DYN1.95B Healthcare Biotechnology -59.91% 2.67% Liquidia
LQDA1.93B Healthcare Biotechnology 101.17% 312.32% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Praxis Precision Medicines Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Praxis Precision's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -60.98%, the Debt to Equity ratio from the most recent quarter is 0.19, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for PRAX?
- Looking at Praxis Precision's growth, its revenue over the trailing twelve months (TTM) was $8M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of -100.00%.
- How much of PRAX stock is held by insiders and institutions?
- Wondering who owns Praxis Precision stock? Company insiders (like executives and directors) hold about 0.20% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 113.34%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.